The sooner, the better: Early beta-blocker administration in patients with ST-elevation myocardial infarction

Critical Care Medicine

Volumn 41, Issue 6, 2013, Pages 1566-1568

  Roolvink, Vincent ^a   Van'T Hof, Arnoud W J ^a   Van Der Horst, Iwan C C ^b  

^a Isala Klinieken ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

beta blockers; infarct size; mortality; myocardial infarction; reperfusion therapy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; METOPROLOL;

CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; EARLY INTERVENTION; EDITORIAL; HEART INFARCTION SIZE; HEART VENTRICLE FIBRILLATION; HUMAN; NECROSIS; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE DRUG DOSE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ADRENERGIC BETA-ANTAGONISTS; CARDIAC CARE FACILITIES; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION;

EID: 84878559561     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318283ce8b     Document Type: Editorial

References (16)

1. Metoprolol in Acute Myocardial Infarction (MIAMI). A randomized placebo-controlled international trial: the MIAMI Trial Research Group. Eur Heart J 1985; 6:199-226
2. Randomized trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1: First International Study of Infarct Survival Collaborative Group. Lancet 1986; 2:57-66
3. Domanski MJ, Zipes DP, Schron E: Treatment of sudden cardiac death. Current understandings from randomized trials and future research directions. Circulation 1997; 95:2694-2699
4. López-Sendón J, Swedberg K, McMurray J, et al; Task Force on Beta-Blockers of the European Society of Cardiology: Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J 2004; 25:1341-1362
5. Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-seg-ment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J 2012; 33:2569-2619
6. Hammerman H, Kloner RA, Briggs LL, et al: Enhancement of salvage of reperfused myocardium by early beta-adrenergic blockade (timo-lol). J Am Coll Cardiol 1984; 3:1438-1443
7. Rasmussen MM, Reimer KA, Kloner RA, et al: Infarct size reduction by propranolol before and after coronary ligation in dogs. Circulation 1977; 56:794-798
8. Van de Werf F, Vanhaecke J, Jang IK, Flameng W, Collen D, De Geest H: Reduction in infarct size and enhanced recovery of systolic function after coronary thrombolysis with tissue-type plasminogen activator combined with beta-adrenergic blockade with metoprolol. Circulation 1987; 75:830-836
9. Kern KB, Hilwig RW, Warner A, et al: Failure of intravenous metopro-lol to limit acute myocardial infarct size in a nonreperfused porcine model. Am Heart J 1995; 129:650-655
10. Peter T, Heng MK, Singh BN, et al: Failure of high doses of proprano-lol to reduce experimental myocardial ischemic damage. Circulation 1978; 57:534-540
11. COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group: Early intravenous then oral metoprolol in 45852 patients with acute myocardial infarction: randomized placebo-controlled trial. Lancet 1995; 366:1622-1632
12. Brandler E, Paladino L, Sinert R: Does the early administration of beta-blockers improve the in-hospital mortality rate of patients admitted with acute coronary syndrome? Acad Emerg Med 2010; 17:1-10
13. Ibanez B, Prat-González S, Speidl WS, et al: Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation 2007; 115:2909-2916
14. Ibanez B, Fuster V, Macaya C, et al: Study design for the "effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion" (METOCARD-CNIC): A randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metopro-lol administration in ST-segment elevation myocardial infarction. Am Heart J 2012; 164:473-480.e5
15. Roolvink V, Rasoul S, Ottervanger JP, et al: Study design for Early Beta blocker Administration before reperfusion in patients with ST-elevation Myocardial Infarction who are planned to undergo primary PCI. (EARLY-BAMI): A randomized, placebo controlled, double-blinded clinical trial of early administration of intravenous beta-blockers in patients with ST-elevation myocardial infarction before planned primary PCI. Available at: http://www.clinicaltrialsregister.eu. Accessed November 13, 2012
16. Hirschl MM, Wollmann CG, Erhart F, et al: Beneft of Immediate Beta-Blocker Therapy on Mortality in Patients With ST-Segment Elevation Myocardial Infarction. Crit Care Med 2012; 41:1396-1404